Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lei

Showing results (151-160 of 262) with videos related to

Pageof 27
Sort By:
Frontiers in Pharmacology|September 15, 2022
Epithelial immunomodulation by aerosolized Toll-like receptor agonists prevents allergic inflammation in airway mucosa in miceDavid L Goldblatt, Gabriella Valverde Ha, Shradha Wali, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2018
DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancerRyoichi Matsunuma, Doug W Chan, Beom-Jun Kim, et al.
Cancer Research|April 18, 2023
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast CancerXuxu Gou, Beom-Jun Kim, Meenakshi Anurag, et al.
Allergy|December 21, 2013
Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological studyH Zhong, Z Song, W Chen, et al.
Journal of Dental Research|August 31, 2019
Prevention of Postdental Procedure Bacteremia: A Network Meta-analysisB S Zeng, S Y Lin, Y K Tu, et al.
Nature Communications|July 17, 2025
Publisher Correction: Comprehensive evaluation of phosphoproteomic-based kinase activity inferenceSophia Müller-Dott, Eric J Jaehnig, Khoi Pham Munchic, et al.
Nature Communications|May 22, 2025
Comprehensive evaluation of phosphoproteomic-based kinase activity inferenceSophia Müller-Dott, Eric J Jaehnig, Khoi Pham Munchic, et al.
Cancer Discovery|August 13, 2017
Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast CancerSvasti Haricharan, Nindo Punturi, Purba Singh, et al.
The British Journal of Dermatology|April 8, 2020
Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regionsP Lin, S Zhu, Y Huang, et al.
Genome Medicine|April 9, 2026
Co-occurrence of transcriptionally distinct persister cell states underpins neoadjuvant therapy resistance in triple‑negative breast cancerYu Zhang, Fatemeh Ahmadi Moughari, Ioanna Mavrommati, et al.
Pageof 27

Showing results (151-160 of 262) with videos related to

Sort By:
Pageof 27
Frontiers in Pharmacology|September 15, 2022
Epithelial immunomodulation by aerosolized Toll-like receptor agonists prevents allergic inflammation in airway mucosa in miceDavid L Goldblatt, Gabriella Valverde Ha, Shradha Wali, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2018
DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancerRyoichi Matsunuma, Doug W Chan, Beom-Jun Kim, et al.
Cancer Research|April 18, 2023
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast CancerXuxu Gou, Beom-Jun Kim, Meenakshi Anurag, et al.
Allergy|December 21, 2013
Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological studyH Zhong, Z Song, W Chen, et al.
Journal of Dental Research|August 31, 2019
Prevention of Postdental Procedure Bacteremia: A Network Meta-analysisB S Zeng, S Y Lin, Y K Tu, et al.
Nature Communications|July 17, 2025
Publisher Correction: Comprehensive evaluation of phosphoproteomic-based kinase activity inferenceSophia Müller-Dott, Eric J Jaehnig, Khoi Pham Munchic, et al.
Nature Communications|May 22, 2025
Comprehensive evaluation of phosphoproteomic-based kinase activity inferenceSophia Müller-Dott, Eric J Jaehnig, Khoi Pham Munchic, et al.
Cancer Discovery|August 13, 2017
Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast CancerSvasti Haricharan, Nindo Punturi, Purba Singh, et al.
The British Journal of Dermatology|April 8, 2020
Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regionsP Lin, S Zhu, Y Huang, et al.
Genome Medicine|April 9, 2026
Co-occurrence of transcriptionally distinct persister cell states underpins neoadjuvant therapy resistance in triple‑negative breast cancerYu Zhang, Fatemeh Ahmadi Moughari, Ioanna Mavrommati, et al.
Pageof 27